219 related articles for article (PubMed ID: 20368082)
1. High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease.
Chen GL; Liu LW; Xie S; Liu H; Liu YQ; Li YS
Chin Med J (Engl); 2010 Mar; 123(6):658-63. PubMed ID: 20368082
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease.
Wang DX; Liu H; Yan LR; Zhang YP; Guan XY; Xu ZM; Jia YH; Li YS
Chin Med J (Engl); 2013; 126(19):3656-61. PubMed ID: 24112159
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris.
Korita I; Bulo A; Langlois MR; Verhoye E; Blaton V
Clin Biochem; 2013 Nov; 46(16-17):1660-3. PubMed ID: 23994331
[TBL] [Abstract][Full Text] [Related]
5. Increasing apoA-I production as a target for CHD risk reduction.
Dullens SP; Plat J; Mensink RP
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):616-28. PubMed ID: 17703927
[TBL] [Abstract][Full Text] [Related]
6. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
[TBL] [Abstract][Full Text] [Related]
7. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects.
Dullaart RP; de Boer JF; Annema W; Tietge UJ
Obesity (Silver Spring); 2013 Feb; 21(2):361-6. PubMed ID: 23404653
[TBL] [Abstract][Full Text] [Related]
8. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
[TBL] [Abstract][Full Text] [Related]
9. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
10. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
11. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
12. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
13. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
14. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
Rubins HB; Schectman G; Wilt TJ; Iwane MK
Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
[TBL] [Abstract][Full Text] [Related]
15. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
[TBL] [Abstract][Full Text] [Related]
16. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
17. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
[TBL] [Abstract][Full Text] [Related]
19. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Rothenbacher D; Brenner H; März W; Koenig W
Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
